Wealth Enhancement Advisory Services
CHRS icon

Wealth Enhancement Advisory Services’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$27.8K Buy
34,275
+1,026
+3% +$831 ﹤0.01% 3243
2025
Q1 		$26.8K Buy
33,249
+2,402
+8% +$1.94K ﹤0.01% 2864
2024
Q4 		$42.6K Buy
30,847
+15,214
+97% +$21K ﹤0.01% 2838
2024
Q3 		$16.3K Buy
+15,633
New +$16.3K ﹤0.01% 2608